Potassium Supplement

Verify with FDA CVM →

20 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
20
Total Reports
4
Deaths Reported
2000.0%
Death Rate

Active Ingredients

Potassium Supplement

Administration Routes

UnknownOralSubcutaneous

Species Affected

Cat 14
Dog 6

Most Affected Breeds

Domestic Shorthair 11
Chihuahua 1
Collie - Border 1
Shih Tzu 1
Schipperke 1
Sheepdog (unspecified) 1
Cat (unknown) 1
Domestic Mediumhair 1
Retriever - Labrador 1
Maine Coon 1

Most Reported Reactions

Weight loss 4
Behavioural disorder NOS 3
Decreased appetite 3
Urinary incontinence 3
Lack of efficacy - NOS 3
Hypokalaemia 3
Other abnormal test result NOS 2
Vomiting 2
Increased percentage reticulocytes 2
Elevated alanine aminotransferase (ALT) 2
Neutrophilia 2
Diarrhoea 2

Outcome Breakdown

Ongoing
8 (40.0%)
Recovered/Normal
6 (30.0%)
Outcome Unknown
2 (10.0%)
Died
2 (10.0%)
Euthanized
2 (10.0%)

Data Summary

Metric Value
Total adverse event reports 20
Reports involving death 4
Case-fatality rate (reported events) 2000.0%
Distinct species in reports 2
Distinct breeds in reports 10
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Potassium Supplement Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 20 adverse event reports referencing Potassium Supplement, including 4 reports in which the animal died — a 2000.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Potassium Supplement. Reported administration routes include Unknown, Oral, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Potassium Supplement reports are Cat (14 reports), Dog (6 reports), with Cat accounting for the largest share. Within those species, Domestic Shorthair (11), Chihuahua (1), Collie - Border (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Potassium Supplement are Weight loss (4), Behavioural disorder NOS (3), Decreased appetite (3), Urinary incontinence (3). Of the 20 reports with a coded outcome, Ongoing is the leading category at 40.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Potassium Supplement.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial